Literature DB >> 2061809

Intestinal malrotation: the role of small intestinal dysmotility in the cause of persistent symptoms.

R C Coombs1, R G Buick, P G Gornall, J J Corkery, I W Booth.   

Abstract

To investigate the possibility that small intestinal dysmotility is a cause of long-standing and persistent symptoms in patients with malrotation, we retrospectively reviewed 94 patients operated on for intestinal malrotation. In 50 patients operated on during the neonatal period, associated abnormalities were common (24%) and all presented with obstructive symptoms; only three (6%) had continuing mild symptoms the postneonatal period (aged 1 month to 1 year), five of whom (22%) had other abnormalities. Recurrent vomiting was the most common presentation (11/23); only 5 patients (21%) had acute obstruction. Response to operation was good in 18 (78%) and two had persistant symptoms; both died. Twenty-one patients presented beyond infancy (aged greater than 1 year), only 19 of whom had symptoms of less than 2 months' duration. Eight (47%) of those with long-standing symptoms had no relief from operation. Small bowel motility was recorded manometrically in 4 patients with long-standing symptoms. The findings suggest that small intestinal dysmotility may be common in patients with malrotation and persistant symptoms.

Entities:  

Mesh:

Year:  1991        PMID: 2061809     DOI: 10.1016/0022-3468(91)90705-x

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  8 in total

1.  Cisapride reduces neonatal postoperative ileus: randomised placebo controlled trial.

Authors:  A Lander; R Redkar; G Nicholls; A Lawson; S R Choudhury; J J Corkery; P Gornall; R G Buick; I W Booth
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-09       Impact factor: 5.747

2.  Delayed gastric emptying in gastroesophageal reflux disease: the role of malrotation.

Authors:  Savaş Demirbilek; Abdurrahman Karaman; Kubilay Gürünlüoğlu; Melih Akin; Erkan Taş; Rauf Tuğrul Aksoy; Ersoy Kekilli
Journal:  Pediatr Surg Int       Date:  2005-05-24       Impact factor: 1.827

Review 3.  Anomalies of intestinal rotation and fixation: consequences of late diagnosis beyond two years of age.

Authors:  J M Moran Penco; J Cardenal Murillo; Antonio Hernández; Urbano De La Calle Pato; Diego Fernando Masjoan; F Romero Aceituno
Journal:  Pediatr Surg Int       Date:  2007-06-27       Impact factor: 1.827

4.  Long-term complications following intestinal malrotation and the Ladd's procedure: a 15 year review.

Authors:  Feilim Liam Murphy; Anthony L Sparnon
Journal:  Pediatr Surg Int       Date:  2006-03-04       Impact factor: 1.827

5.  Rare copy number variants contribute pathogenic alleles in patients with intestinal malrotation.

Authors:  Karin Salehi Karlslätt; Maria Pettersson; Nina Jäntti; Przemyslaw Szafranski; Tomas Wester; Britt Husberg; Ulla Ullberg; Pawel Stankiewicz; Ann Nordgren; Johanna Lundin; Anna Lindstrand; Agneta Nordenskjöld
Journal:  Mol Genet Genomic Med       Date:  2019-01-10       Impact factor: 2.183

6.  Is There a Need for Bowel Management after Surgery for Isolated Intestinal Malrotation in Children?

Authors:  Martin Salö
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2019-09-11

Review 7.  Gastroesophageal Reflux Disease and Foregut Dysmotility in Children with Intestinal Failure.

Authors:  Anna Rybak; Aruna Sethuraman; Kornilia Nikaki; Jutta Koeglmeier; Keith Lindley; Osvaldo Borrelli
Journal:  Nutrients       Date:  2020-11-18       Impact factor: 5.717

8.  Five Hundred Patients With Gut Malrotation: Thirty Years of Experience With the Introduction of a New Surgical Procedure.

Authors:  Kareem Abu-Elmagd; George Mazariegos; Sherif Armanyous; Neha Parekh; Ayat ElSherif; Ajai Khanna; Beverly Kosmach-Park; Giuseppe D'Amico; Masato Fujiki; Mohammed Osman; Marissa Scalish; Amanda Pruchnicki; Elizabeth Newhouse; Ahmed A Abdelshafy; Erick Remer; Guilherme Costa; R Matthew Walsh
Journal:  Ann Surg       Date:  2021-10-01       Impact factor: 12.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.